Skip to content

SAD and MAD study of VES001

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505847-38-00
Acronym
CHDR2309
Enrollment
78
Registered
2023-10-11
Start date
2023-10-11
Completion date
2024-07-26
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frontotemporal dementia (FTD)

Interventions

None listed

Sponsors

Insusense ApS, Insusense ApS
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026